Table 1 Characteristics of the subjects.

From: CUN‑BAE predicts risk of metabolic dysfunction–associated steatotic liver disease: A prospective cohort study in non‑obese Chinese adults

 

Male

 

Female

 

MASLD

No

Yes

P-value

No

Yes

P-value*

N

7189

1294

 

6662

1028

 

Age, years

45.55 ± 16.31

47.29 ± 16.26

< 0.001

40.20 ± 12.69

41.48 ± 12.85

< 0.001

Height, cm

164.79 ± 7.85

167.66 ± 7.63

< 0.001

163.27 ± 7.51

166.49 ± 7.80

< 0.001

Weight, kg

57.73 ± 8.39

65.48 ± 7.36

< 0.001

56.09 ± 7.87

64.23 ± 7.38

< 0.001

BMI, kg/m2

21.18 ± 2.02

23.23 ± 1.32

< 0.001

20.97 ± 1.96

23.11 ± 1.35

< 0.001

SBP, mmHg

120.47 ± 16.53

128.74 ± 16.32

< 0.001

118.43 ± 16.41

127.27 ± 15.63

< 0.001

DBP, mmHg

72.54 ± 10.26

78.31 ± 10.27

< 0.001

71.35 ± 9.94

77.21 ± 10.26

< 0.001

ALT, U/L

16.00

(13.00–19.00)

21.00

(16.00–30.00)

< 0.001

16.00

(13.00–17.00)

21.00

(16.00–29.00)

< 0.001

AST, U/L

21.00

(19.00–23.00)

23.00

(20.00–27.00)

< 0.001

21.00

(19.00–22.00)

23.00

(20.00–27.00)

< 0.001

TP, g/L

73.94 ± 3.92

73.97 ± 4.07

0.967

73.80 ± 4.07

74.12 ± 4.12

0.023

ALB, g/L

44.51 ± 2.66

44.49 ± 2.56

0.891

44.27 ± 2.51

44.48 ± 2.66

0.008

GLB, g/L

29.42 ± 3.65

29.46 ± 3.94

0.725

29.53 ± 3.68

29.63 ± 3.82

0.321

BUN, mmol/L

4.61 ± 1.38

4.64 ± 1.26

0.251

4.51 ± 1.38

4.56 ± 1.29

0.239

CR, µmo/L

79.08 ± 26.73

86.66 ± 18.40

< 0.001

75.27 ± 25.72

84.77 ± 21.83

< 0.001

UA, mmol/L

279.38 ± 84.80

330.27 ± 83.94

< 0.001

263.77 ± 80.95

323.29 ± 88.22

< 0.001

eGFR, (mL/min·1.73 m2)

107.22 ± 31.47

93.88 ± 34.49

< 0.001

85.48 ± 23.29

73.12 ± 19.40

< 0.001

TC, mmol/L

4.59 ± 0.73

4.81 ± 0.82

< 0.001

4.60 ± 0.73

4.79 ± 0.73

< 0.001

TG, mmol/L

1.23 ± 0.82

2.04 ± 1.56

< 0.001

1.14 ± 0.62

1.92 ± 1.29

< 0.001

HDL-C, mmol/L

1.48 ± 0.36

1.29 ± 0.32

< 0.001

1.50 ± 0.36

1.31 ± 0.32

< 0.001

LDL-C, mmol/L

2.25 ± 0.47

2.40 ± 0.46

< 0.001

2.24 ± 0.46

2.40 ± 0.44

< 0.001

FPG, mmol/L

5.11 ± 0.71

5.46 ± 0.97

< 0.001

5.07 ± 0.74

5.44 ± 1.05

< 0.001

CUN-BAE

18.36 ± 4.35

21.82 ± 3.14

< 0.001

29.36 ± 3.97

32.93 ± 2.82

< 0.001

TYG

8.39 ± 0.49

8.93 ± 0.54

< 0.001

8.33 ± 0.48

8.87 ± 0.56

< 0.001

  1. Values were expressed as mean (SD) or medians (Q1-Q3);.
  2. Abbreviations: ALB, Albumin; ALP, Alkaline phosphatase; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, Body mass index; BUN, Blood urea nitrogen; Cr, Creatinine; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; DBP, Diastolic blood pressure; eGFR estimated glomerular filtration rate; FPG, Fasting plasma glucose; GGT, Gamma-glutamyl transferase; GLB, Globulin; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease; SBP, Systolic blood pressure; TC, Total cholesterol; TG, Triglyceride; TP, Total Protein; TYG, Triglyceride-Glucose index; UA, Uric acid.
Back to article page